Roy Bannister
Impact in
-
- Toxic Organic Pollutants Impact
- Effects and risks of endocrine disrupting chemicals
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral Infections and Vectors
- HIV/AIDS drug development and treatment
Papers in
-
- Toxic Organic Pollutants Impact 9
- Effects and risks of endocrine disrupting chemicals 4
-
- SARS-CoV-2 and COVID-19 Research 4
- Viral Infections and Outbreaks Research 4
- COVID-19 Clinical Research Studies 3
- Co-authors
- Stephen SafeTomáš CihlářD. DavisS. SafeС. А. РабиновичJames T. BaldiniTimothy R. ZacharewskiIan R. Tizard
- Journals
- Chemosphere (6 papers)Toxicology (3 papers)Scientific Reports (2 papers)Nature Medicine (1 paper)Occupational and Environmental Medicine (1 paper)
- Partner nations
- United StatesThailand
In The Last Decade
Roy Bannister
24 papers receiving 843 citations
Peers
Comparison fields: 5 of 94
- Health, Toxicology and Mutagenesis 275
- Infectious Diseases 317
- Cancer Research 164
- Pharmacology 76
- Virology 36
Countries citing papers authored by Roy Bannister
This map shows the geographic impact of Roy Bannister's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Bannister with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Bannister more than expected).
Fields of papers citing papers by Roy Bannister
This network shows the impact of papers produced by Roy Bannister. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Bannister. The network helps show where Roy Bannister may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Roy Bannister, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 1 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 5 | |
| 6 | 2021 | 12 | |
| 7 | 2021 | 10 | |
| 8 | 2020 | 50 | |
| 9 | 2020 | 41 | |
| 10 | 2019 | 179 | |
| 11 | 2018 | 10 | |
| 12 | 2014 | 190 | |
| 13 | 1992 | 48 | |
| 14 | 1989 | 2 | |
| 15 | 1989 | 1 | |
| 16 | 1987 | 93 | |
| 17 | 1987 | 62 | |
| 18 | 1987 | 3 | |
| 19 | 1986 | 3 | |
| 20 | 1969 | 67 |
About Roy Bannister
Roy Bannister is a scholar working on Health, Toxicology and Mutagenesis, Infectious Diseases, Cancer Research, Pharmacology and Emergency Medical Services, having authored 24 papers that have together received 880 indexed citations. Recurring topics across this work include Toxic Organic Pollutants Impact (9 papers), Carcinogens and Genotoxicity Assessment (7 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Effects and risks of endocrine disrupting chemicals (4 papers), Viral Infections and Outbreaks Research (4 papers), Respiratory viral infections research (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (275 citations), Infectious Diseases (317 citations), Cancer Research (164 citations), Pharmacology (76 citations) and Virology (36 citations). Roy Bannister has collaborated with scholars based in United States and Thailand. Frequent co-authors include Stephen Safe, Tomáš Cihlář, D. Davis, S. Safe, С. А. Рабинович, James T. Baldini, Timothy R. Zacharewski, Ian R. Tizard, Bernard P. Murray and Xuexiang Zhang. Their work appears in journals such as Chemosphere, Toxicology, Scientific Reports, Nature Medicine and Occupational and Environmental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.